Observations on the effects of inhaled isoflurane in long-term sedation of critically ill children using a modified AnaConDa©-system

Klinische Padiatrie

Volumn 225, Issue 4, 2013, Pages 206-211

  Eifinger, F ^a   Hunseler C ^a   Roth, B ^a   Vierzig, A ^a   Oberthuer, A ^a   Mehler, K ^a   Kribs, A ^a   Menzel, C ^a   Trieschmann, U ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

AnaConDa; anesthesia; isoflurane; pediatric intensive care; prolonged sedation

Indexed keywords

4 HYDROXYBUTYRIC ACID; CLONIDINE; FENTANYL; ISOFLURANE; KETAMINE; MIDAZOLAM; MORPHINE; REMIFENTANIL;

ABSENCE OF SIDE EFFECTS; ANESTHESIA LEVEL; ANESTHETIC EQUIPMENT; ANESTHETIC VAPORIZER; ARTICLE; CHILD; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; DRUG DELIVERY SYSTEM; DRUG USE; FEMALE; HUMAN; INFANT; INFUSION PUMP; LONG TERM CARE; MALE; PEDIATRIC ANESTHESIA; SEDATION; SYRINGE; TRACHEOSTOMY;

ANESTHESIA, INHALATION; CONSCIOUS SEDATION; CRITICAL ILLNESS; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; ISOFLURANE; LONG-TERM CARE; MALE; NERVE DEGENERATION; RETROSPECTIVE STUDIES; RISK FACTORS; TRACHEOTOMY;

EID: 84881174861     PISSN: 03008630     EISSN: 14393824     Source Type: Journal    
DOI: 10.1055/s-0033-1345173     Document Type: Article

References (36)

1. Ariyama J., Hayashida M., Shibata K. et al. Risk factors for the development of reversible psychomotor dysfunction following prolonged isoflurane inhalation in the general intensive care unit. J Clin Anesth: 2009; 21 567 573
2. Arnold J. H., Truog R. D., Molengraft J. A. Tolerance to isoflurane during prolonged administration. Anesthesiology: 1993; 78 985 988 (Pubitemid 23141377)
3. Arnold J. H., Truog R. D., Rice S. A. Prolonged administration of isoflurane to pediatric patients during mechanical ventilation. Anesth Analg: 1993; 76 520 526 (Pubitemid 23077107)
4. Bergman I., Steeves M., Burckart G. et al. Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration. J Pediatr: 1991; 119 644 649
5. Bisonnette B., Leon J. E. Cerebrovascular stability during isoflurane anaesthesia in children. Can J Anaesth: 1992; 39 128 134
6. Bosel J., Purrucker J. C., Nowak F. et al. Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa((R)): effects on cerebral oxygenation, circulation, and pressure. Intensive Care Med: 2012; 38 1955 1964
7. Brambrink A. M., Back S. A., Riddle A. et al. Isoflurane-induced apoptosis of oligodendrocytes in the neonatal primate brain. Ann Neurol: 2012; 72 525 535
8. Chen H., Burris M., Fajilan A. et al. Prolonged Exposure to Isoflurane Ameliorates Infarction Severity in the Rat Pup Model of Neonatal Hypoxia-Ischemia. Transl Stroke Res: 2011; 2 382 390
9. Haase R., Lieser U., Kramm C. et al. Management of oncology patients admitted to the paediatric intensive care unit of a general children's hospital - a single center analysis. Klin Padiatr: 2011; 223 142 146
10. Hartwig S., Roth B., Theisohn M. Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit. Eur J Pediatr: 1991; 150 784 788
11. Hausdorfer J., Hagemann H., Bell M. et al. Isoflurane in pediatric anesthesia. Anaesthesist: 1986; 35 345 352
12. Hoemberg M., Vierzig A., Roth B. et al. Plasma fluoride concentrations during prolonged administration of isoflurane to a pediatric patient requiring renal replacement therapy. Paediatr Anaesth: 2012; 22 412 413
13. Hofmann S. R., Stadler K., Heilmann A. et al. Stabilisation of cardiopulmonary function in newborns with congenital diaphragmatic hernia using lung function parameters and hemodynamic management. Klin Padiatr: 2012; 224 241 246
14. Hollmann M. W., Liu H. T., Hoenemann C. W. et al. Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics. Anesth Analg: 2001; 92 1182 1191 (Pubitemid 32385940)
15. Jung C., Granados M., Marsol P. et al. Use of sevoflurane sedation by the AnaConDa device as an adjunct to extubation in a pediatric burn patient. Burns: 2008; 34 136 138
16. Loepke A. W., Istaphanous G. K., McAuliffe J. J. III et al. The effects of neonatal isoflurane exposure in mice on brain cell viability, adult behavior, learning, and memory. Anesth Analg: 2009; 108 90 104
17. Lu Y., Wu X., Dong Y. et al. Anesthetic sevoflurane causes neurotoxicity differently in neonatal naive and Alzheimer disease transgenic mice. Anesthesiology: 2010; 112 1404 1416
18. Luginbuehl I. A., Fredrickson M. J., Karsli C. et al. Cerebral blood flow velocity in children anaesthetized with desflurane. Paediatr Anaesth: 2003; 13 496 500 (Pubitemid 36842962)
19. Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res Brain Res Rev: 1999; 30 289 304 (Pubitemid 29531489)
20. Marx C. M., Smith P. G., Lowrie L. H. et al. Optimal sedation of mechanically ventilated pediatric critical care patients. Crit Care Med: 1994; 22 163 170
21. Matchett G. A., Allard M. W., Martin R. D. et al. Neuroprotective effect of volatile anesthetic agents: molecular mechanisms. Neurol Res: 2009; 31 128 134
22. Michel-Behnke I., Rothes A., Hund F. et al. Analgosedation with fentanyl/midazolam after correction of congenital heart defects. Klin Padiatr: 1995; 207 341 346
23. Olsson G. L. Inhalational anaesthesia at the extremes of age: paediatric anaesthesia. Anaesthesia: 1995; 50 (Suppl) 34 36
24. Ostermann M. E., Keenan S. P., Seiferling R. A. et al. Sedation in the intensive care unit: a systematic review. JAMA: 2000; 283 1451 1459 (Pubitemid 30151824)
25. Prader A. Normal growth and disorders of growth in children and adolescents. Klin Wochenschr: 1981; 59 977 984 (Pubitemid 11046713)
26. Revell S., Greenhalgh D., Absalom S. R. et al. Isoflurane in the treatment of asthma. Anaesthesia: 1988; 43 477 479
27. Sackey P. V., Martling C. R., Carlsward C. et al. Short- and long-term follow-up of intensive care unit patients after sedation with isoflurane and midazolam - a pilot study. Crit Care Med: 2008; 36 801 806
28. Sackey P. V., Martling C. R., Granath F. et al. Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device. Crit Care Med: 2004; 32 2241 2246 (Pubitemid 39491803)
29. Sackey P. V., Martling C. R., Radell P. J. Three cases of PICU sedation with isoflurane delivered by the 'AnaConDa'. Paediatr Anaesth: 2005; 15 879 885 (Pubitemid 43961341)
30. Schifilliti D., Grasso G., Conti A. et al. Anaesthetic-related neuroprotection: intravenous or inhalational agents? CNS Drugs: 2010; 24 893 907
31. Schmidt B., Adelmann C., Stutzer H. et al. Comparison of sufentanil versus fentanyl in ventilated term neonates. Klin Padiatr: 2010; 222 62 66
32. Shankar V., Churchwell K. B., Deshpande J. K. Isoflurane therapy for severe refractory status asthmaticus in children. Intensive Care Med: 2006; 32 927 933 (Pubitemid 43781379)
33. Soukup J., Scharff K., Kubosch K. et al. State of the art: sedation concepts with volatile anesthetics in critically Ill patients. J Crit Care: 2009; 24 535 544
34. Sponheim S., Skraastad O., Helseth E. et al. Effects of 0.5 and 1.0 MAC isoflurane, sevoflurane and desflurane on intracranial and cerebral perfusion pressures in children. Acta Anaesthesiol Scand: 2003; 47 932 938 (Pubitemid 37013766)
35. Tobias J. D. Therapeutic applications and uses of inhalational anesthesia in the pediatric intensive care unit. Pediatr Crit Care Med: 2008; 9 169 179 (Pubitemid 351355022)
36. Wren W. S., McShane A. J., McCarthy J. G. et al. Isoflurane in paediatric anaesthesia. Induction and recovery from anaesthesia. Anaesthesia: 1985; 40 315 323 (Pubitemid 15114306)